Home › Clinical Trials › Cancer Clinical Trial › Cervix Uteri › (CIRB) Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy

Print
A A A

Important information about COVID-19 ›

(CIRB) Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy

Protocol Number: GOG-0724

NCT Number: NCT00980954

Condition/Disease: Cancer - Cervix Uteri

Principal Investigator: Krishnansu Tewari

Status: Open

Treatment: Treatment

Drugs: Carboplatin, Cisplatin, Paclitaxel, Paraplatin, Taxol

Phase: III

Age Group: Adult

Scope: Local

Learn More:
For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.